Personalized, Gene-Based Risk Testing For Lung Cancer Gives New Tool To Help Smokers Quit

Tue, 29 Sep 2009 18:10:00 0500

PHILADELPHIA-(Business Wire)-September 29, 2009 - Smokers who learn their personal risk of lung cancer through gene-based risk assessment are more likely to be motivated to quit their habit, according to Dr. W. Jeffrey Allard, clinical affairs director of Synergenz Bioscience Ltd.

ABL and Evivar Medical Enter into Agreements to Form a Global Strategic Partnership and IP Cross-Licensing for Disease Management and Personalized Healthcare of Hepatitis B and HIV Infections

Tue, 29 Sep 2009 16:00:00 0500

LUXEMBOURG & MELBOURNE, Australia-(Business Wire)-September 29, 2009 - ABL, S.A. and Evivar Medical Pty Ltd today announced the completion of agreements to cross-licence their respective intellectual property portfolios and to form strategic alliances based on the use of their...

Top Life Sciences Attorney to Join Intrexon as Chief Legal Officer

Tue, 29 Sep 2009 15:08:00 0500

BLACKSBURG, Va.-(Business Wire)-September 29, 2009 - Intrexon Corporation, a privately held life sciences company focused on modular DNA control systems for biotherapeutics and other industry sectors, today announced the appointment of Asher M. Rubin as Executive Vice President, Chief Legal...

Luminex Corporation Hosts Seventh Annual Planet xMAP Europe

Tue, 29 Sep 2009 14:00:00 0500

Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced that it will host Planet xMAP Europe 2009, its annual European multiplexing technology symposium, October 7-8, 2009, at Beurs van Berlage in Amsterdam. The program for...

Bio Japan 2009: The Biggest Biotechnology Event in Japan.

Tue, 29 Sep 2009 13:07:00 0500

YOKOHAMA, Japan-(Business Wire)-September 29, 2009 - We would like to thank you sincerely for your understanding and ongoing cooperation for BioJapn.

With your wholehearted support, BioJapan has been progressing successfully in both its contents and scale every year...

Pluristem Therapeutics Has Been Selected to Present at The Israeli Presidential Conference 2009: Facing Tomorrow, Based on the Company’s Proprietary Technology and the Potential to Shape The Future of the Stem Cell Industry

Tue, 29 Sep 2009 13:06:00 0500

HAIFA, Israel-(Business Wire)-September 29, 2009 - Pluristem Therapeutics Inc. (NasdaqCM: PSTI...

Life Technologies Foundation Awards $1.7 Million in Grants to Advance Science

Tue, 29 Sep 2009 12:03:00 0500

CARLSBAD, Calif.-(Business Wire)-September 29, 2009 - The Life Technologies Foundation, a non-profit arm of Life Technologies Corporation (NASDAQ: LIFE) dedicated to advancing science education and scientific discovery, has awarded approximately $1.7 million in new grants that include the...

Computable Genomix Announces Contest For Genomics Researchers

Tue, 29 Sep 2009 12:00:00 0500

MEMPHIS, Tenn.-(Business Wire)-September 29, 2009 - Memphis-based Computable Genomix today announced it will launch a contest on Oct. 1, 2009, to coincide with the release of GeneIndexer, the company’s next-generation Web-based text-mining tool.

Publish or Perish will...

SAIC-Frederick and Roche Enter into a Research Collaboration on Technology Advancements for Cancer Gene Sequencing

Tue, 29 Sep 2009 12:00:00 0500

MADISON, Wis.-(Business Wire)-September 29, 2009 - National Cancer Institute contractor SAIC-Frederick, Inc., a wholly owned subsidiary of Science Applications International Corporation (NYSE: SAI), and Roche Applied Science, a division of Roche Diagnostics Corporation (SWX:RO) (SWX:ROG) (Pink...

Scarab Genomics Introduces ScarabXpress™ T7lac, a unique E. coli expression strain

Tue, 29 Sep 2009 11:27:00 0500

MADISON, Wis.-(Business Wire)-September 29, 2009 - ScarabXpress is the latest strain in the multiple-deletion series (MDS) of Scarab Genomics Clean Genome^® E. coli. Based on the MDS™42 strain, ScarabXpress T7lac contains a chromosomal copy of the T7 RNA polymerase gene...

PPD Announces Third Quarter 2009 Earnings Release, Webcast and Conference Call

Tue, 29 Sep 2009 10:00:00 0500

WILMINGTON, N.C.-(Business Wire)-September 29, 2009 - PPD, Inc. (Nasdaq: PPDI) will release its third quarter 2009 financial results on Tuesday, October 27, 2009, after the market closes. The earnings release will be available on the PPD Web site at febit holding GmbH

Dyax Corp. to Present at the JMP Securities Healthcare Focus Conference

Fri, 25 Sep 2009 11:30:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 25, 2009 - Dyax Corp. (NASDAQ:DYAX), a developer of novel biotherapeutics for unmet medical needs, announced today that Gustav A. Christensen, President and Chief Executive Officer of Dyax, will present at the Fourth Annual JMP Securities Healthcare...

HRC Fertility Offers Gene Security Parental Control for Embryonic Safety

Thu, 24 Sep 2009 16:55:00 0500

PASADENA, Calif.-(Business Wire)-September 24, 2009 - Over the past twenty-one years, HRC Fertility has...

TRADE NEWS: Agilent Technologies, Shanghai Institute of Biological Sciences and Chinese Academy of Sciences Open Center for Systems Biology

Thu, 24 Sep 2009 15:00:00 0500

SANTA CLARA, Calif. & SHANGHAI-(Business Wire)-September 24, 2009 - Agilent Technologies Inc. (NYSE:A) today announced the opening of the Shanghai Institute of Biological Sciences (SIBS)-Agilent Center for Systems Biology in Shanghai, China. The center will feature multiple technology...

Health Discovery Corporation’s Dr. Stephen Barnhill Tells Participants at London Conference That Biomarkers Patented by His Company Promise to Revolutionize The Field of Molecular Diagnostics

Thu, 24 Sep 2009 13:15:00 0500

SAVANNAH, Ga.-(Business Wire)-September 24, 2009 - Dr. Stephen Barnhill, Chairman and CEO, Health Discovery Corporation (OTCBB: HDVY) (“HDC”), a molecular diagnostics company, spoke at the “Biomarkers in Clinical Trials” Conference taking place in London, September 23-24, 2009. The...

Pfizer Launches Phase 3 Clinical Trial With Novel Alk Inhibitor In Non-Small Cell Lung Cancer Patients With Specific Gene Mutation

Thu, 24 Sep 2009 12:28:00 0500

BERLIN-(Business Wire)-September 24, 2009 - Pfizer Oncology announced today that it will initiate a global, Phase 3 clinical trial of its investigational oral c-Met and ALK inhibitor, PF-02341066, versus standard of care chemotherapy in patients with advanced non-small cell lung cancer (NSCLC...

Helicos Announces First-Ever Direct Sequencing of Single Molecules of RNA

Thu, 24 Sep 2009 11:30:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 24, 2009 - Helicos BioSciences Corporation (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies, today announced the publication of a landmark study in which Helicos’ True Single Molecule Sequencing (tSMS...

Life Technologies Initiates Suit Against Illumina Alleging Patent Infringement

Thu, 24 Sep 2009 01:22:00 0500

SAN DIEGO-(Business Wire)-September 24, 2009 - Illumina, Inc. (Nasdaq:ILMN) today announced that it has been served with a complaint filed on September 21, 2009 in the U.S. District Court in Wilmington, Delaware naming Illumina as a defendant. The complaint names as plaintiffs Life...

PsoriasisDX and HairDX To Present “Pharmacogenomics In Dermatology And Cosmetics” During EADV Congress

Wed, 23 Sep 2009 18:11:00 0500

BERLIN & IRVINE, Calif.-(Business Wire)-September 23, 2009 - A symposium about “Pharmacogenomics In Dermatology And Cosmetics” will be presented on Thursday, October 8 to coincide with the 18th European Academy of Dermatology and Venereology (EADV) Congress. It will be held at the...

BioPharm America™ 2009 in San Francisco Sets New Benchmark for Partnering Productivity in the US

Wed, 23 Sep 2009 17:59:00 0500

CARLSBAD, Calif. & SAN FRANCISCO-(Business Wire)-September 23, 2009 - Over 700 leaders from the biotechnology and pharmaceutical industry gathered last week for the 2nd annual BioPharm America™ partnering conference, which saw delegates from 665 companies engage in 1579 one-to-one...

RainDance Expands Sequence Enrichment Solution Capabilities with 20,000 Amplicon Library and Whole Genome Amplification Protocol

Wed, 23 Sep 2009 17:30:00 0500

PROVIDENCE, R.I.-(Business Wire)-September 23, 2009 - RainDance Technologies, Inc., a leading provider of innovative microdroplet-based solutions for health and human disease research, announced today it has expanded the capabilities of its Sequence Enrichment Solution to enable the...

Perlegen Introduces BREVAGen™ Breast Cancer Risk Stratification Test

Wed, 23 Sep 2009 16:53:00 0500

MOUNTAIN VIEW, Calif.-(Business Wire)-September 23, 2009 - Perlegen Sciences, which develops genetic tests that correlate genetic variation to disease risk and drug response, announced today that its BREVAGen™ breast cancer risk stratification test is now clinically available in select U.S...

LifeSensors, Inc. Obtains Worldwide, Exclusive License to High Affinity “Ubiquitin Traps”

Wed, 23 Sep 2009 15:16:00 0500

MALVERN, Pa.-(Business Wire)-September 23, 2009 - LifeSensors, Inc., a biotechnology company specializing in protein expression technologies and ubiquitin pathway research tools, announced today their worldwide, exclusive license for high affinity ubiquitin traps. These new research tools...

Merck and QIAGEN Collaborate to Accelerate Access to Cervical Cancer Vaccination and Screening in Developing Countries

Wed, 23 Sep 2009 13:11:00 0500

NEW YORK-(Business Wire)-September 23, 2009 - Merck & Co., Inc. and QIAGEN N.V. today announced their intent to collaborate on a new program to increase access to HPV vaccination and HPV DNA testing in some of the most resource-poor areas of the world. This initiative is the first time a...

Bio-Computing a Major Focus of 22nd Annual SC Conference

Wed, 23 Sep 2009 13:00:00 0500

PORTLAND, Ore.-(Business Wire)-September 23, 2009 - SC09, the 22^nd annual supercomputing...

Genzyme Provides Update on Cerezyme and Fabrazyme Supply

Wed, 23 Sep 2009 12:49:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 23, 2009 - Genzyme Corporation (NASDAQ: GENZ) today provided an update on its progress to restore supplies of Cerezyme® (imiglucerase for injection) and Fabrazyme® (agalsidase beta) for patients worldwide and revised its 2009 revenue guidance for these...

Pluristem Therapeutics Doses First Patient in U.S. With Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease

Wed, 23 Sep 2009 11:00:00 0500

HAIFA, Israel-(Business Wire)-September 23, 2009 - Pluristem Therapeutics Inc. (NasdaqCM: PSTI...

Top 20 Pharma Firms to Hunt for Deals at BIO-Europe 2009

Tue, 22 Sep 2009 18:37:00 0500

ZURICH & VIENNA-(Business Wire)-September 22, 2009 - In order to seek out new partnering opportunities, the top 20 big pharma companies will be in attendance on November 2–4 in Vienna, Austria for BIO-Europe 2009, the largest dedicated partnering conference in Europe. Teams of scouts from...

Genetic Hair Loss Test Now Introduced In Australia Through HairDX Distribution Agreement With Advanced Hair Studio

Tue, 22 Sep 2009 15:18:00 0500

IRVINE, Calif. & EAST MELBOURNE, VICTORIA, Australia-(Business Wire)-September 22, 2009 - Men and women in Australia now have access to

TRADE NEWS: Agilent Technologies Adds Human Exon Kit to Next-Generation-Sequencing Target Enrichment Portfolio

Tue, 22 Sep 2009 15:00:00 0500

PROVIDENCE, R.I.-(Business Wire)-September 22, 2009 - Agilent Technologies Inc. (NYSE:A) has chosen the Cambridge Health Institute’s Next-Generation Sequencing Analysis conference today to introduce its SureSelect Human All Exon Kit for target enrichment prior to next-generation DNA sequencing...

Curis to Present at Maxim Group Growth Conference 2009

Tue, 22 Sep 2009 12:00:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 22, 2009 - Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the Maxim Group Growth Conference...

Helicos Presents at Cold Spring Harbor Laboratories Personal Genomes and CHI Next Generation Sequencing Meetings

Tue, 22 Sep 2009 11:30:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 22, 2009 - Helicos BioSciences Corporation (NASDAQ: HLCS) provided updates on recent scientific findings and progress on Helicos’s technology initiatives.

Speaking at the Personal Genomes conference in Cold Spring Harbor, NY, and the...

Mentor Capital, Inc. Completes 2nd Year Audit for OTCBB Move; Reporting $0.16 Per Share in Basic Earnings

Mon, 21 Sep 2009 19:29:00 0500

SAN DIEGO-(Business Wire)-September 21, 2009 - Mentor Capital, Inc. (Pink Sheets:MNTR) completed its FY 2008 audit in preparation for filing a self-registration statement with the SEC and applying to move from the Pink Sheets to begin being quoted on the Over-the-Counter Bulletin Board system...

BioForward Announces Winners of Biotechnology Vision Summit’s Emerging Company Showcase

Mon, 21 Sep 2009 16:26:00 0500

MADISON, Wis.-(Business Wire)-September 21, 2009 - Six Wisconsin biotechnology companies have been selected the winners of the first Emerging Company Showcase. The showcase is part of the Biotechnology Vision Summit 2009, being held on Wednesday, Oct. 7, at the Madison Marriott West in Madison...

Sloning Closes Growth Financing Round Led by LBBW Venture

Mon, 21 Sep 2009 13:41:00 0500

PUCHHEIM, Germany-(Business Wire)-September 21, 2009 - Sloning BioTechnology GmbH, the worldwide leading supplier of combinatorial gene libraries, received additional investments from all of its institutional shareholders: HBM BioVentures, LBBW Venture, DEWB and KfW to finance the company’s...

NABsys Expands Leadership Team with Appointment of Stan Rose to Board of Directors

Mon, 21 Sep 2009 13:00:00 0500

PROVIDENCE, R.I.-(Business Wire)-September 21, 2009 - NABsys Inc. announced today that industry veteran and serial entrepreneur, Stan Rose, Ph.D., has been appointed to the company’s board of directors. Dr. Rose is the most recent addition to the leadership team at NABsys, which recently raised...

Dicerna Pharmaceuticals to Present at 2009 Biologics Drug Delivery & Beyond Conference

Mon, 21 Sep 2009 12:30:00 0500

WATERTOWN, Mass.-(Business Wire)-September 21, 2009 - Dicerna Pharmaceuticals, Inc., a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™ and dicer substrate RNAi molecules, today announced that Sujit K. Basu...

Biogen Idec Commences Tender Offer for Facet Biotech

Mon, 21 Sep 2009 12:15:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 21, 2009 - Biogen Idec Inc. (NASDAQ:BIIB) announced today that FBC Acquisition Corp., its wholly owned subsidiary, has commenced a tender offer to acquire all of the outstanding shares of Facet Biotech Corporation (NASDAQ:FACT) for $14.50 per share in...

PerkinElmer Launches Columbus™ 2.0 High Content Screening Platform for High-Volume Image Data Management and Analysis

Mon, 21 Sep 2009 12:00:00 0500

BOSTON-(Business Wire)-September 21, 2009 - At the High Content Analysis East conference...

Enzo Biochem and National Institutes of Health to Cooperate in Development of Enzo’s Novel Therapeutic Candidate for Treatment of Autoimmune Uveitis

Mon, 21 Sep 2009 11:36:00 0500

NEW YORK-(Business Wire)-September 21, 2009 - Enzo Biochem, Inc. (NYSE: ENZ), announced today that it had entered into a Cooperative Research and Development Agreement (CRADA) with the National Eye Institute, part of the National Institute of Health, to conduct a human clinical trial of...

Pacific Biosciences Expands Mission and Prepares for Commercialization

Mon, 21 Sep 2009 11:30:00 0500

MENLO PARK, Calif.-(Business Wire)-September 21, 2009 - Pacific Biosciences, a private company developing a disruptive technology platform for real-time detection of biological events at single molecule resolution, today provided a number of updates to its commercial strategy and progress...

ZymoGenetics Appoints Dennis M. Miller, Ph.D., Senior Vice President, Research and Preclinical Development

Fri, 18 Sep 2009 20:30:00 0500

SEATTLE-(Business Wire)-September 18, 2009 - ZymoGenetics, Inc. (NASDAQ:ZGEN) announced today that Dennis M. Miller, Ph.D. has been promoted to the position of Senior Vice President of Research and Preclinical Development and will serve as a member of the company’s executive management...

From Ancient Bones to the Future of DNA Technologies: Forensic Experts Gather for Exclusive Symposium on Human Identity

Fri, 18 Sep 2009 16:00:00 0500

MADISON, Wis.-(Business Wire)-September 18, 2009 - The

Enzo Biochem’s Life Sciences Unit Introduces Novel System for Simultaneous Live-Cell Imaging of Nuclear Components

Thu, 17 Sep 2009 12:00:00 0500

FARMINGDALE, N.Y.-(Business Wire)-September 17, 2009 - Enzo Life Sciences, a division of Enzo Biochem, Inc. (NYSE:ENZ), has added a novel new system to its CELLestial™ line of live cell analysis products, providing expanded capability to simultaneously image both the nucleus and the nucleolus...

Navigenics Welcomes Michael Critelli to Board of Directors

Thu, 17 Sep 2009 12:00:00 0500

FOSTER CITY, Calif.-(Business Wire)-September 17, 2009 - Navigenics, a leading personal genomics testing company, announced today that Michael J. Critelli has been appointed to its board of directors.

Upon his retirement in February 2009, Mr. Critelli completed a nearly 30-year...

Roche’s xCELLigence System and FuGENE® HD Transfection Reagent Minimize Cytotoxic Effects in the Detection of Bax-Induced Apoptosis

Thu, 17 Sep 2009 12:00:00 0500

PENZBERG, Germany-(Business Wire)-September 17, 2009 - Transfection is a way to transiently or permanently deliver nucleic acids into eukaryotic cells to study functional effects in response to altered gene expression and for protein production. In a recent study (1) the xCELLigence System for...

RainDance Technologies and CLC bio Collaborate to Develop Specialized Software Solutions for Targeted Resequencing

Thu, 17 Sep 2009 12:00:00 0500

LEXINGTON, Mass. & AARHUS, Denmark-(Business Wire)-September 17, 2009 - RainDance Technologies and CLC bio today announced a partnership to develop specialized software for the analysis of targeted resequencing data generated by workflows incorporating RainDance’s Sequence Enrichment...

World-Class Scholars to Use Evolutionary Theory in Search for Solutions to High-Risk Adolescent Behavior

Thu, 17 Sep 2009 11:00:00 0500

TUCSON, Ariz.-(Business Wire)-September 17, 2009 - The Evolution Institute and the University of Arizona's Frances McClelland Institute for Children, Youth, and Families are co-hosting an invitation-only workshop at the university, Oct. 30 - Nov. 2, for world-renowned scholars who will apply...

EBD Group and Defined Health Form an Alliance on Conference Content

Wed, 16 Sep 2009 23:40:00 0500

CARLSBAD, Calif. & ZURICH, Switzerland & FLORHAM PARK, N.J.-(Business Wire)-September 16, 2009 - EBD Group and Defined Health today announced the formation of an alliance that will help biopharmaceutical firms gain the insights they need to create and execute successful strategy. Under...

Alnylam to Webcast Presentation at UBS Global Life Sciences Conference

Wed, 16 Sep 2009 20:23:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 16, 2009 - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the UBS Global Life Sciences Conference on Monday, September 21, 2009, at 12:00 p.m. ET at...

Bioheart Inc. Announces Positive Results in the MARVEL Phase II/III Clinical Trial

Wed, 16 Sep 2009 20:00:00 0500

SUNRISE, Fla.-(Business Wire)-September 16, 2009 - Bioheart, Inc. (OTCBB:

Research and Markets: Principles of Genetics, Take Note!, 4th Edition

Wed, 16 Sep 2009 14:51:00 0500

DUBLIN-(Business Wire)-September 16, 2009 - Research and Markets (Cyntellect, Inc., a privately-held life sciences company...

Enzo Biochem to Present at UBS Global Life Sciences Conference

Wed, 16 Sep 2009 12:00:00 0500

NEW YORK-(Business Wire)-September 16, 2009 - Enzo Biochem, Inc. (NYSE:ENZ), a leading biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications, announced today that Barry Weiner, President, and David...

PerkinElmer Purchases GE Healthcare’s Catalog Radiochemicals, SPA Reagents and Cytostar-T Plate Assets

Wed, 16 Sep 2009 12:00:00 0500

WALTHAM, Mass.-(Business Wire)-September 16, 2009 - PerkinElmer, Inc., a global leader focused on improving the health and safety of people and their environment, today announced that it has purchased the assets of GE Healthcare’s ³H and ¹⁴C Catalog Radiochemicals...

Applied Biosystems Launches New Genomic Analysis Tools that Simplify Disease Research

Wed, 16 Sep 2009 11:30:00 0500

CARLSBAD, Calif.-(Business Wire)-September 16, 2009 - Applied Biosystems, part of Life Technologies Corporation (NASDAQ:LIFE), today announced the launch of genomic analysis tools that will help researchers in studies that associate genetic variation with specific diseases. These new...

Inovio Biomedical CEO to Present at MIT Technology Review Emerging Technology Conference

Wed, 16 Sep 2009 10:00:00 0500

SAN DIEGO-(Business Wire)-September 16, 2009 - Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that Dr. J. Joseph Kim, CEO, has been invited to present at EmTech, the Emerging Technologies Conference hosted by MIT and...

Fluidigm and Quimica Valaner Team Together in Mexican Distribution Deal

Tue, 15 Sep 2009 16:40:00 0500

SOUTH SAN FRANCISCO, Calif. & MEXICO CITY-(Business Wire)-September 15, 2009 - Fluidigm Corporation, the inventor of integrated fluidic circuits (IFCs), has appointed Química Valaner S.A de C.V as exclusive distributor for Fluidigm’s industry-leading instrumentation and chips in Mexico...

Breakthrough Genetic Test Helps Doctors Assess Risk Of Developing Psoriatic Arthritis (PsA)

Tue, 15 Sep 2009 15:12:00 0500

IRVINE, Calif.-(Business Wire)-September 15, 2009 - The first genetic test for Psoriatic arthritis (PsA) is being launched today by

Cipher Uses DSG’s EDC in Effort to Give Hope to Severe Acne Sufferers

Mon, 14 Sep 2009 11:00:00 0500

MALVERN, Pa.-(Business Wire)-September 14, 2009 - DSG Inc., an industry leader in clinical trial data collection and management, today announced that Cipher Pharmaceuticals (TSX:DND) is using electronic data capture (EDC) software and data management services from DSG. Cipher is using DSG’s...

7 Million Babies and Children and 6 Million Hispanics in the U.S. Have Acid Reflux

Mon, 14 Sep 2009 08:35:00 0500

WASHINGTON-(Business Wire)-September 14, 2009 - (NAPSW) The Pediatric Adolescent Gastroesophageal Reflux (PAGER) Association has been helping families learn about acid reflux since 1992. The medical name for the disease is gastroesophageal reflux. It means stomach + esophagus + backwash...

FDA and EMEA Grant Orphan Drug Designation for Antisense Pharma's Investigational Drug Trabedersen in Pancreatic Carcinoma

Mon, 14 Sep 2009 07:58:00 0500

REGENSBURG, Germany-(Business Wire)-September 14, 2009 - The biopharmaceutical company Antisense Pharma GmbH has announced today that it has received orphan drug designation from both the European Medicines Agency EMEA and the US Food and Drug Administration FDA for its investigational drug...

Osiris Therapeutics to Present at ThinkEquity and UBS Conferences

Fri, 11 Sep 2009 21:44:00 0500

COLUMBIA, Md.-(Business Wire)-September 11, 2009 - Osiris Therapeutics, Inc. (NASDAQ:OSIR), the...

ACAM Partners with Jonathan Wright, MD and Daved Rosensweet, MD to Produce Comprehensive Hormone Seminar

Fri, 11 Sep 2009 16:41:00 0500

IRVINE, Calif.-(Business Wire)-September 11, 2009 - The American College for Advancement in Medicine (ACAM) announced today that it will co-produce a seminar with Johnathan Wright, MD and Daved Rosensweet, MD titled “Female & Male Endocrine Seminar: Enhancing the vitality of your patients...

Genzyme’s Alemtuzumab for Multiple Sclerosis Shows Durable Treatment Benefit in Review of Four-Year Phase 2 Trial Data

Fri, 11 Sep 2009 15:44:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 11, 2009 - Genzyme Corporation (Nasdaq: GENZ) reported today that...

Data Supporting Unique Efficacy of TYSABRI Presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis

Fri, 11 Sep 2009 13:30:00 0500

DUSSELDORF, Germany-(Business Wire)-September 11, 2009 - Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced data presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) showing the potential of...

LabCorp is Scheduled to Present at the UBS 2009 Global Life Sciences Conference

Fri, 11 Sep 2009 13:00:00 0500

BURLINGTON, N.C.-(Business Wire)-September 11, 2009 - Laboratory Corporation of America^® Holdings (LabCorp^®) (NYSE:LH) today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the UBS 2009 Global Life Sciences Conference in New...

BioMarker Strategies Raises $1.7 Million, Including Investment by Abell Foundation

Fri, 11 Sep 2009 11:47:00 0500

BALTIMORE-(Business Wire)-September 11, 2009 - BioMarker Strategies announced today that it has raised $1.7 million in a private placement funding round that occurred in conjunction with the Maryland Biotechnology Investment Incentive Tax Credit Program. BioMarker Strategies is developing the...

New Ohio Bioscience Resource Directory Keeps Pace with Industry Sector’s Growth

Thu, 10 Sep 2009 15:00:00 0500

COLUMBUS, Ohio-(Business Wire)-September 10, 2009 - BioOhio and the Global Cardiovascular Innovation Center (GCIC) have launched an expanded and improved Ohio Bioscience Resource Directory, the most comprehensive online collection of Ohio companies, organizations, and research centers involved in...

American Diversified Holdings Corporation to Be Featured Presenter at the International Stem Cell Network's New York City Symposium

Thu, 10 Sep 2009 13:00:00 0500

DEL MAR, Calif.-(Business Wire)-September 10, 2009 - Ernest B. Remo, Chairman/CEO of American Diversified Holdings Corporation (Pink Sheets:ADHC) announced that the company will be a featured presenter at a symposium sponsored by the International Stem Cell Network scheduled for the week of...

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Morgan Stanley Conference

Thu, 10 Sep 2009 12:00:00 0500

ROCKVILLE, Md.-(Business Wire)-September 10, 2009 - Human Genome Sciences, Inc. (NASDAQ: HGSI) announced today that its presentation at the 2009 Morgan Stanley Global Healthcare Unplugged Conference will be webcast and may be accessed at

NATURE REVIEWS DRUG DISCOVERY Publishes Epizyme-authored Paper on Protein Methyltransferases

Wed, 09 Sep 2009 12:30:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 9, 2009 - A paper underscoring the importance of protein methyltransferases (PMTs) in drug discovery is published in the September 2009 online issue of NATURE REVIEWS DRUG DISCOVERY. Scientists Dr. Robert A. Copeland and Dr. Victoria M. Richon from...

Enzo Biochem to Present at Thomas Weisel Partners 2009 Healthcare Conference

Wed, 09 Sep 2009 12:00:00 0500

NEW YORK-(Business Wire)-September 9, 2009 - Enzo Biochem, Inc. (NYSE:ENZ), a leading biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications, announced today that Barry Weiner, President, and David...

Constellation Pharmaceuticals Appoints Renowned Cancer Biologist Edward E. Harlow, Jr., Ph.D. as Company’s CSO

Wed, 09 Sep 2009 12:00:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 9, 2009 - Constellation Pharmaceuticals, Inc. today announced that it has appointed Edward E. Harlow, Jr., Ph.D. as the company’s Chief Scientific Officer. This appointment reflects the Company’s strong scientific heritage and its progress in...

Complete Genomics Demonstrates Its Technology’s Potential by Sequencing 14 Human Genomes for Customers

Wed, 09 Sep 2009 12:00:00 0500

MOUNTAIN VIEW, Calif.-(Business Wire)-September 9, 2009 - Complete Genomics Inc., a third-generation human genome sequencing company, announced today that it has sequenced, analyzed and delivered 14 human genomes to customers since March 2009. Considering that fewer than 20 genomes have been...

Inspire Wins North Carolina Health & Life Sciences Award for Cystic Fibrosis Development Program

Wed, 09 Sep 2009 11:00:00 0500

DURHAM, N.C.-(Business Wire)-September 9, 2009 - Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today it received the North Carolina Health & Life Sciences Award in the category of “Breakthrough Research” for its denufosol tetrasodium program for cystic fibrosis (CF). This award...

Cytori Therapeutics Announces Fall U.S. Medical Conference Presentation Schedule; Interim RESTORE-2 Results to be Reported in December

Wed, 09 Sep 2009 11:00:00 0500

SAN DIEGO-(Business Wire)-September 9, 2009 - Cytori Therapeutics, Inc. (NASDAQ:CYTX) announced today its fall medical conference presentation schedule. The Company will present clinical and preclinical results on the use of adipose tissue-derived stem and regenerative cells or will be exhibiting...

Neuralstem Receives Notice of Patent Allowance

Wed, 09 Sep 2009 10:00:00 0500

ROCKVILLE, Md.-(Business Wire)-September 9, 2009 - Neuralstem, Inc. (NYSE Amex: CUR) today announced that it has received notice of allowance from the United States Patent and Trademark Office (USPTO) for its patent entitled “Transplantation of Human Neural Cells For Treatment Of...

Rosetta Genomics Reports Second Quarter Financial Results, Provides Business Update

Tue, 08 Sep 2009 20:05:00 0500

PHILADELPHIA & REHOVOT, Israel-(Business Wire)-September 8, 2009 - Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based molecular diagnostics, today reported financial results for the three and six months ended June 30, 2009. Highlights of the second quarter of 2009...

Biogen Idec Reiterates Proposal to Acquire All Outstanding Shares of Facet for $14.50 Per Share in Cash

Tue, 08 Sep 2009 20:03:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 8, 2009 - Biogen Idec Inc. (NASDAQ:BIIB) today reiterated its proposal to acquire all of the outstanding shares of Facet Biotech Corporation for $14.50 per share in cash.

James C. Mullen, Biogen Idec’s President and Chief Executive...

Exact Sciences to Present at Baird, Rodman & Renshaw Conferences

Tue, 08 Sep 2009 18:19:00 0500

MADISON, Wis.-(Business Wire)-September 8, 2009 - Exact Sciences Corp. (Nasdaq: EXAS) today announced that it will present at Robert W. Baird & Co.’s 2009 Health Care Conference, which is being held Sept. 9-10, at the Four Seasons Hotel in New York, and the Rodman & Renshaw Annual...

Response Genetics, Inc. to Present at the Rodman & Renshaw 11th Annual Healthcare Conference

Tue, 08 Sep 2009 16:34:00 0500

LOS ANGELES-(Business Wire)-September 8, 2009 - Response Genetics, Inc. (Nasdaq:RGDX) announced today that its president and CEO, Kathleen Danenberg, will present at the Rodman & Renshaw 11^th Annual Healthcare Conference at 5:20 p.m. on Thursday, September 10. The conference is...

Amerinet Named Provider of Choice by National Rural Health Association Partnership

Tue, 08 Sep 2009 15:00:00 0500

ST. LOUIS-(Business Wire)-September 8, 2009 - In recognition of their commitment to helping rural healthcare providers reduce costs and improve quality, Amerinet, a leading national healthcare group purchasing organization, has been named a “Provider of Choice” by the National...

Enzo Biochem Appoints Dr. Mohan Chellani, 15-Year Industry Veteran, Vice President of Scientific Affairs at Enzo Clinical Labs

Tue, 08 Sep 2009 14:00:00 0500

NEW YORK-(Business Wire)-September 8, 2009 - Enzo Biochem, Inc. (NYSE:ENZ) today announced the appointment of Mohan Chellani, Ph.D., formerly a senior manager with Quest Diagnostics, as Vice President of Scientific Affairs at its Enzo Clinical Labs subsidiary. He will oversee all aspects of the...

StemCells, Inc. to Present at Two Investor Conferences in September

Tue, 08 Sep 2009 13:10:00 0500

PALO ALTO, Calif.-(Business Wire)-September 8, 2009 - StemCells, Inc. (NASDAQ:STEM) announced today that President and Chief Executive Officer Martin McGlynn will present an update on the Company’s programs and operations at the Thomas Weisel Partners Healthcare Conference 2009 on...

CytRx Receives FDA Letter Regarding Arimoclomol Phase IIb Clinical Trial for ALS

Tue, 08 Sep 2009 12:30:00 0500

LOS ANGELES-(Business Wire)-September 8, 2009 - CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced its intention during the 2009 fourth quarter to submit a revised protocol...

LabCorp is Scheduled to Present at the Bank of America Merrill Lynch Global Healthcare Conference

Tue, 08 Sep 2009 12:30:00 0500

BURLINGTON, N.C.-(Business Wire)-September 8, 2009 - Laboratory Corporation of America^® Holdings (LabCorp^®) (NYSE: LH) today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the Bank of America Merrill Lynch Global Healthcare...

Cell Biosciences Signs Agreement to Acquire Alpha Innotech

Tue, 08 Sep 2009 12:30:00 0500

SANTA CLARA, Calif.-(Business Wire)-September 8, 2009 - Cell Biosciences, Inc. and Alpha Innotech Corp. (OTC BB: APNO.OB) today announced that they have entered into a definitive agreement providing for the acquisition of Alpha Innotech by Cell Biosciences for $1.50 per share, or approximately...

PerkinElmer Announces Acquisition of Prenatal and Newborn Screening Laboratory in India

Tue, 08 Sep 2009 12:01:00 0500

CHENNAI, India-(Business Wire)-September 8, 2009 - PerkinElmer, Inc., a global leader focused on...

BrainStorm Cell Therapeutics to Address Shareholders via a Webcast Audio Conference

Tue, 08 Sep 2009 12:01:00 0500

NEW YORK & PETACH TIKVAH, Israel-(Business Wire)-September 8, 2009 - BrainStorm Cell Therapeutics Inc. (OTCBB:Osiris Therapeutics, Inc. (NASDAQ: OSIR) today...

Enzo Biochem to Present at Rodman & Renshaw Annual Global Investment Conference

Tue, 08 Sep 2009 12:00:00 0500

NEW YORK-(Business Wire)-September 8, 2009 - Enzo Biochem, Inc. (NYSE: ENZ), a leading biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications, announced today that Barry Weiner, President, and David...

Helicos Sells Multiple HeliScope™ Sequencers to RIKEN Institute

Tue, 08 Sep 2009 11:30:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 8, 2009 - Helicos BioSciences Corporation (NASDAQ:HLCS) today announced that the RIKEN Yokohama Institute Omics Science Center (OSC) has agreed to purchase four Helicos™ Genetic Analysis Systems. The transaction represents the first multisystem sale of...

FDA and BioTrove Collaborate to Evaluate BioTrove’s Novel Genetic Profiling and Pathogen Detection System for Possible Use in Detecting Threats to the Nation’s Blood Supply

Tue, 08 Sep 2009 10:30:00 0500

WOBURN, Mass.-(Business Wire)-September 8, 2009 - BioTrove announced a collaboration with the U.S. Food...

Biogen Idec Announces Proposal to Acquire All Outstanding Shares of Facet for $14.50 per Share in Cash

Fri, 04 Sep 2009 15:00:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 4, 2009 - Biogen Idec Inc. (NASDAQ:BIIB) today announced that it has submitted a proposal to the Board of Directors of Facet Biotech Corporation (NASDAQ:FACT) to acquire all of the outstanding shares of Facet for $14.50 per share in cash. The all-cash...

Bio-Computing Day at SC09 to Feature One of the World’s Leading Scientists in Molecular Biotechnology and Genomics

Fri, 04 Sep 2009 13:00:00 0500

PORTLAND, Ore.-(Business Wire)-September 4, 2009 - SC09, the 22nd annual event in the SC conference series, recognized globally as the premier international conference on high performance computing, networking, storage and analysis, announced today it has selected world renowned Biologist...

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners Conference

Fri, 04 Sep 2009 12:00:00 0500

ROCKVILLE, Md.-(Business Wire)-September 4, 2009 - Human Genome Sciences, Inc. (NASDAQ:HGSI) announced today that its presentation at the 2009 Thomas Weisel Partners Healthcare Conference will be webcast and may be accessed at www.wellgen.com), a...

Illumina to Present at Upcoming Investment Conferences in September

Thu, 03 Sep 2009 13:01:00 0500

SAN DIEGO-(Business Wire)-September 3, 2009 - Illumina, Inc. (NASDAQ:ILMN) today announced that the Company will webcast its presentations at three upcoming investment conferences.

Illumina will webcast its presentation at the Thomas Weisel Partners Healthcare Conference in...

XDx to Present at the Thomas Weisel 2009 Healthcare Conference

Thu, 03 Sep 2009 12:30:00 0500

BRISBANE, Calif.-(Business Wire)-September 3, 2009 - XDx, Inc., a molecular diagnostics company focused on noninvasive gene expression tests for the monitoring of immune-mediated conditions, today announced that Pierre Cassigneul, president and chief executive officer, is scheduled to present...

Neurologix to Present at Rodman & Renshaw 11th Annual Healthcare Conference

Thu, 03 Sep 2009 12:00:00 0500

FORT LEE, N.J.-(Business Wire)-September 3, 2009 - Neurologix, Inc. (OTCBB: NRGX), a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, announced today that it is scheduled to present at the Rodman & Renshaw...

Curis Announces GDC-0449 Phase I Clinical Data Published in New England Journal of Medicine

Thu, 03 Sep 2009 12:00:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 3, 2009 - Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing proprietary targeted medicines for cancer treatment, today announced that two publications describing clinical data generated with GDC-0449 were published in the...

Dyax Corp. to Present at Four Investor Conferences in September

Thu, 03 Sep 2009 11:30:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 3, 2009 - Dyax Corp. (NASDAQ:DYAX), a developer of novel biotherapeutics for unmet medical needs, announced today that Gustav A. Christensen, President and Chief Executive Officer, and other senior management of Dyax will present at four investor...

SuperGen to Present at September Investment Conferences

Thu, 03 Sep 2009 10:00:00 0500

DUBLIN, Calif.-(Business Wire)-September 3, 2009 - SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief Executive Officer, will present at two upcoming...

Enabling Capabilities of Inovio Biomedical’s Electroporation Delivery Technology with SIV DNA Vaccine Confirmed in Collaborative Study With National Cancer Institute

Thu, 03 Sep 2009 07:00:00 0500

SAN DIEGO-(Business Wire)-September 3, 2009 - Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that data generated from a pre-clinical collaborative study by National Cancer Institute (NCI) and Inovio scientists were...

NeoMatrix to Sponsor Congressional Event on Young Women and Breast Cancer

Wed, 02 Sep 2009 20:21:00 0500

WASHINGTON-(Business Wire)-September 2, 2009 - NeoMatrix, makers of the HALO™ Breast Pap Test, is a sponsor of a congressional reception Sept. 9 on Capitol Hill, which will focus on the EARLY Act and raising awareness about young women’s breast cancer risk.

Among the speakers...

Rosetta Genomics to Hold Second Quarter Conference Call on September 8

Wed, 02 Sep 2009 20:00:00 0500

REHOVOT, Israel & PHILADELPHIA-(Business Wire)-September 2, 2009 - Rosetta Genomics (NASDAQ: ROSG) today announced it will release financial results for the second quarter of 2009 on September 8, 2009 after the close of NASDAQ trading, and will host a conference call and webcast to...

Rosetta Genomics to Present at the Rodman & Renshaw 11th Annual Healthcare Conference

Wed, 02 Sep 2009 20:00:00 0500

PHILADELPHIA & REHOVOT, Israel-(Business Wire)-September 2, 2009 - Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based molecular diagnostics, announced that Amir Avniel, president and chief executive officer, will be presenting a corporate update at the...

Dicerna Pharmaceuticals to Present at Upcoming Conferences

Wed, 02 Sep 2009 12:30:00 0500

WATERTOWN, Mass.-(Business Wire)-September 2, 2009 - Dicerna Pharmaceuticals, Inc., a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™ and dicer substrate RNAi molecules, today announced that James C. Jenson...

Ikonisys to Present at the Thomas Weisel Partners Healthcare Conference 2009

Wed, 02 Sep 2009 12:05:00 0500

NEW HAVEN, Conn.-(Business Wire)-September 2, 2009 - Ikonisys announced today that Dr. Petros Tsipouras, Chairman and Chief Executive Officer, will present at the Thomas Weisel Partners Healthcare Conference 2009.

Presentation details are as follows:
Receptor Logic, Inc.

Life Technologies to Sell Mass Spectrometry Business to Danaher for $450 Million in Cash

Wed, 02 Sep 2009 11:07:00 0500

CARLSBAD, Calif.-(Business Wire)-September 2, 2009 - Life Technologies Corporation (NASDAQ:LIFE) today announced it has signed a definitive agreement to sell its ownership stake in its mass spectrometry business, operated as a joint venture, to Danaher Corporation (NYSE:DHR) for $450 million in...

FDA Advisory Committee Recommends Randomized Trial to Support Proposed Indication for Clolar in Adult AML

Tue, 01 Sep 2009 19:34:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 1, 2009 - Genzyme Corporation (Nasdaq: GENZ) announced today that...

Dyax Corp. Announces Expanded Roles for Two Senior Management Executives as Company Advances Commercialization Plan

Tue, 01 Sep 2009 16:30:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 1, 2009 - Dyax Corp. (NASDAQ:DYAX), a developer of novel biotherapeutics for unmet medical needs, announced today that two senior executives will be taking on expanded roles reflecting the Company’s continued growth and plans for commercialization...

Strategic Product Development Expert to Educate Utah Technology Company Executives

Tue, 01 Sep 2009 15:36:00 0500

SALT LAKE CITY-(Business Wire)-September 1, 2009 - The Utah Technology Council (UTC), Utah’s premier professional organization, today announced that Dr. Steven Wheelwright will speak on “Leadership and Growth through Product Development” at its annual educational event on Sept. 10, from...

Metabasis Therapeutics Announces the Resignation of Mark Erion, Ph.D., Metabasis’ President, CEO & CSO

Tue, 01 Sep 2009 12:00:00 0500

SAN DIEGO-(Business Wire)-September 1, 2009 - Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced today that Mark Erion, PhD, the Company’s president, chief executive officer and chief scientific officer as well as a member of its board of directors, has resigned as an officer and director...

Prof. Offen to Discuss Latest Progress of Brainstorm Today on Israeli National Radio

Tue, 01 Sep 2009 11:33:00 0500

NEW YORK & PETACH TIKVAH, Israel-(Business Wire)-September 1, 2009 - BrainStorm Cell Therapeutics (OTCBB:BCLI), announces that Prof. Daniel Offen – Brainstorm’s Chief Scientist will be interviewed today, September 1^st between 08:00-09:00 AM EST on Reshet Bet, the Israeli...

Intrexon Announces Purchase of Industry-Leading Bioassay Operation

Tue, 01 Sep 2009 11:10:00 0500

BLACKSBURG, Va.-(Business Wire)-September 1, 2009 - Intrexon Corporation, a privately held life sciences company focused on modular DNA control systems for biotherapeutics and other industry sectors, today announced the purchase of assets and operations of Avalon Pharmaceutical, Inc., a...

Bio-Matrix Scientific Group Inc. Chairman Comments on New Opportunities for both the Company and Its Majority Owned Subsidiary Entest BioMedical Inc.

Tue, 01 Sep 2009 10:30:00 0500

SAN DIEGO-(Business Wire)-September 1, 2009 - Bio-Matrix Scientific Group, Inc. (OTCBB:BMSN) Chairman & CEO David Koos commented on the Company’s new opportunities in stem cell research, cancer treatment and intellectual property. Mr. Koos noted, “In the last 3 months we have made...

Gene Signal and Collaborators Publish GS-101 Clinical Data Suggesting Safe and Effective Inhibition of Abnormal Ophthalmic Blood Vessel Growth

Tue, 01 Sep 2009 07:00:00 0500

LAUSANNE, Switzerland-(Business Wire)-September 1, 2009 - Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced the publication of interim results from a phase II study suggesting that the antisense oligonucleotide GS-101 (eye...

Illumina Announces Delivery of the First Genome Through Its Individual Genome Sequencing Service

Mon, 31 Aug 2009 13:00:00 0500

SAN DIEGO-(Business Wire)-August 31, 2009 - Illumina, Inc. (NASDAQ:ILMN) today announced that it has delivered Hermann Hauser’s genome sequence. Dr. Hauser, Partner, Amadeus Capital Partners Ltd, is the first consumer to purchase Illumina’s individual genome sequencing service...

BrainStorm Cell Therapeutics Enters into Agreement for Clinical-Grade Stem Cell Production for ALS

Mon, 31 Aug 2009 12:00:00 0500

NEW YORK & PETACH TIKVAH, Israel-(Business Wire)-August 31, 2009 - BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today that it has entered into an agreement with Protein Production Services Ltd. (PPS), a leading...

Celladon Corporation and Momentum Research Complete Enrollment of MYDICAR® Phase 2 Study of First-in-Human Gene Transfer to Treat Patients with Advanced Heart Failure

Mon, 31 Aug 2009 12:00:00 0500

SAN DIEGO-(Business Wire)-August 31, 2009 - Celladon Corporation and Momentum Research, Inc. today announced completion of enrollment of the phase 2 double-blind portion of the Calcium Up-regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) trial. Momentum Research...

DNA Vaccine Company Inovio Biomedical to Present at Rodman & Renshaw Investor Healthcare Conference

Mon, 31 Aug 2009 07:00:00 0500

SAN DIEGO-(Business Wire)-August 31, 2009 - Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that the company's President and Chairman of the Board, Avtar Dhillon, MD, will present at Rodman & Renshaw’s...

FDA Advisory Committee to Discuss Genzyme’s Clolar for Adult AML on September 1

Fri, 28 Aug 2009 16:22:00 0500

CAMBRIDGE, Mass.-(Business Wire)-August 28, 2009 - Genzyme Corporation (Nasdaq: GENZ) announced today that...

First Human Immunology Challenge Symposium Announced by NIH’s National Heart, Lung and Blood Institute’s (NHLBI) Center for Human Immunology (CHI)

Thu, 27 Aug 2009 18:35:00 0500

BETHESDA, Md.-(Business Wire)-August 27, 2009 - NIH’s National Heart, Lung and Blood Institute’s CENTER FOR HUMAN IMMUNOLOGY (CHI) announces the first Meeting the Human Immunology Challenge Symposium. This two-day meeting will be held September 3-4, 2009 on the NIH Campus...

Ligand to Present at Thomas Weisel Partners on September 9

Wed, 26 Aug 2009 13:10:00 0500

SAN DIEGO-(Business Wire)-August 26, 2009 - Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that John L. Higgins, President and Chief Executive Officer, will be presenting at the Thomas Weisel Partners Healthcare Conference 2009 on Wednesday, September 9, at 9:10 a.m...

Fluidigm: 250 Million Microfluidic Valves Manufactured -- and Counting

Wed, 26 Aug 2009 13:00:00 0500

SINGAPORE-(Business Wire)-August 26, 2009 - Fluidigm today announced that its Singapore biochip factory has manufactured and shipped more than 250 million microscopic NanoFlex™ valves. The 250 million valves built into Fluidigm’s integrated fluidic circuits (IFCs) would be equivalent to the...

BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter for Fiscal Year 2009

Wed, 26 Aug 2009 12:30:00 0500

ELMWOOD PARK, N.J.-(Business Wire)-August 26, 2009 - BioReference Laboratories, Inc. (NASDAQ: BRLI) announced today it plans to issue earnings results for the third quarter of fiscal 2009 before the open of market trading on Wednesday, September 2, 2009. The Company’s earnings conference call...

Roche xCELLigence System for Cell Analysis to Provide Predictive Mechanistic Information for Small Molecule Compounds

Wed, 26 Aug 2009 12:00:00 0500

PENZBERG, Germany-(Business Wire)-August 26, 2009 - The extent to which protein targets are modulated by drugs or small molecule compounds depends on a number of factors, including the expression levels of the target, the effective concentration of the compound, and the time needed for the...

Dyax Announces Developments in Licensing and Funded Research Program

Wed, 26 Aug 2009 11:30:00 0500

CAMBRIDGE, Mass.-(Business Wire)-August 26, 2009 - Dyax Corp. (NASDAQ:DYAX) announced today successful advancement into Phase 1 clinical trials of two candidates identified using Dyax’s proprietary phage display technology by licensees of the Company’s Licensing and Funded Research Program...

Sunquest, Partners HealthCare System and Massachusetts General Hospital Announce Agreement to Co-Develop Next Generation Diagnostic Pathology Solutions

Wed, 26 Aug 2009 11:00:00 0500

TUCSON, Ariz.-(Business Wire)-August 26, 2009 - Sunquest Information...

IBM Chief Economist Philip Swan to Discuss Key Worldwide Economic Trends at UTC Special Breakfast Event

Tue, 25 Aug 2009 12:18:00 0500

SALT LAKE CITY-(Business Wire)-August 25, 2009 - The Utah Technology...

LabConnect Appoints Chief Operating Officer

Tue, 25 Aug 2009 11:30:00 0500

SEATTLE-(Business Wire)-August 25, 2009 - LabConnect, LLC, today announced the appointment of Frank D. Morrow, Ph.D., FACN, as its chief operating officer.

Dr. Morrow is a veteran of the central lab business, having served as founding executive, president and chief scientific...

Illumina Announces $75 Million Share Repurchase Program

Mon, 24 Aug 2009 20:01:00 0500

SAN DIEGO-(Business Wire)-August 24, 2009 - Illumina, Inc. (NASDAQ:ILMN) today announced that its Board of Directors has approved a new stock repurchase program, authorizing the Company to repurchase in the aggregate up to $75 million of its outstanding common stock. The Company has terminated...

PacifiCord to Offer Free Prenatal Classes in San Diego

Mon, 24 Aug 2009 15:00:00 0500

IRVINE, Calif.-(Business Wire)-August 24, 2009 - Dedicated to serving the private cord blood banking needs of Southern California, PacifiCord (Pluristem Therapeutics Inc. (NasdaqCM:PSTI...

RainDance Technologies Appoints Patrick Kelly As European Sales Director

Mon, 16 Feb 2009 14:20:00 0500

LEXINGTON, Mass.-(Business Wire)-February 16, 2009 - RainDance Technologies, Inc., a provider of innovative microdroplet-based solutions for human health and disease research, has appointed Patrick Kelly to the newly created position of European Sales Director, effective immediately...

Gene Logic Announces Launch of Illumina SNP Genotyping Services

Mon, 16 Feb 2009 13:54:00 0500

GAITHERSBURG, Md.-(Business Wire)-February 16, 2009 - Gene Logic, an Ocimum Biosolutions company, the leading integrated genomics service provider, has expanded its range of service offerings with the purchase of an Illumina iScan system. The system will be used with the recently released high...

Applied Biosystems and Baylor College of Medicine Summarize Contributions to First Data Release of 1000 Genomes Project

Mon, 16 Feb 2009 12:30:00 0500

CARLSBAD, Calif.-(Business Wire)-February 16, 2009 - Applied Biosystems, a division of Life Technologies (NASDAQ:LIFE), and scientists from the Baylor College of Medicine Human Genome Sequencing Center (HGSC), today summarized their collective contribution to the first data release of the 1000...

Research and Markets: Biomarkers - Technologies, Markets and Companies

Mon, 16 Feb 2009 12:09:00 0500

DUBLIN, Ireland-(Business Wire)-February 16, 2009 - Research and Markets (

Research and Markets: A Comprehensive Analysis of the Worldwide Markets for Gene Amplification Technologies in Millions of US$

Mon, 16 Feb 2009 10:01:00 0500

DUBLIN, Ireland-(Business Wire)-February 16, 2009 - Research and Markets (

VGX Pharmaceuticals Announces Filing of Device Master File Amendment with the FDA for CELLECTRA Device – Intradermal Electroporation (ID-EP)

Fri, 13 Feb 2009 16:20:00 0500

BLUE BELL, Pa.-(Business Wire)-February 13, 2009 - VGX Pharmaceuticals today announced the filing of a Device Master File (MAF) amendment with the U.S. Food and Drug Administration (FDA) for its patented CELLECTRA^® adaptive constant current electroporation device for use with...

Expression Analysis Enters into a Partnership with Complement Genomics Ltd to Offer Genomic Services in the United Kingdom

Fri, 13 Feb 2009 14:17:00 0500

DURHAM, N.C.-(Business Wire)-February 13, 2009 - Expression Analysis, Inc., a leading provider of genomic services for clinical trials and research has entered into a partnership with Sunderland based Complement Genomics Ltd. (

BioImagene Receives FDA 510(k) Clearance for iScan Digital Pathology Hardware

Wed, 11 Feb 2009 15:46:00 0500

CUPERTINO, Calif.-(Business Wire)-February 11, 2009 - BioImagene, the leading provider of innovative digital...

Pluristem Therapeutics Appoints Dr. Frida Grynspan to Vice President of Research and Development

Wed, 11 Feb 2009 15:04:00 0500

NEW YORK-(Business Wire)-February 11, 2009 - Pluristem Therapeutics Inc. (NasdaqCM:PSTI...

Strong Fourth Quarter for Genzyme Concludes Productive Year

Wed, 11 Feb 2009 13:51:00 0500

CAMBRIDGE, Mass.-(Business Wire)-February 11, 2009 - Genzyme Corp. (NASDAQ: GENZ) today announced solid fourth-quarter revenue and earnings growth and provided guidance for 2009 that underscored its positive outlook for the year.

GAAP net income rose to $86.7 million, or $0.31...

Digital50.com Genetics News RSS Feed

Idaho Technology Expands Its High Resolution Melting Patent Portfolio

Celera to Webcast Presentation at JMP Securities 2009 Healthcare Conference

Personalized, Gene-Based Risk Testing For Lung Cancer Gives New Tool To Help Smokers Quit

ABL and Evivar Medical Enter into Agreements to Form a Global Strategic Partnership and IP Cross-Licensing for Disease Management and Personalized Healthcare of Hepatitis B and HIV Infections

Top Life Sciences Attorney to Join Intrexon as Chief Legal Officer

Luminex Corporation Hosts Seventh Annual Planet xMAP Europe

Bio Japan 2009: The Biggest Biotechnology Event in Japan.

Pluristem Therapeutics Has Been Selected to Present at The Israeli Presidential Conference 2009: Facing Tomorrow, Based on the Company’s Proprietary Technology and the Potential to Shape The Future of the Stem Cell Industry

Life Technologies Foundation Awards $1.7 Million in Grants to Advance Science

Computable Genomix Announces Contest For Genomics Researchers

SAIC-Frederick and Roche Enter into a Research Collaboration on Technology Advancements for Cancer Gene Sequencing

Scarab Genomics Introduces ScarabXpress™ T7lac, a unique E. coli expression strain

PPD Announces Third Quarter 2009 Earnings Release, Webcast and Conference Call

Dyax Corp. to Present at the JMP Securities Healthcare Focus Conference

HRC Fertility Offers Gene Security Parental Control for Embryonic Safety

TRADE NEWS: Agilent Technologies, Shanghai Institute of Biological Sciences and Chinese Academy of Sciences Open Center for Systems Biology

Health Discovery Corporation’s Dr. Stephen Barnhill Tells Participants at London Conference That Biomarkers Patented by His Company Promise to Revolutionize The Field of Molecular Diagnostics

Pfizer Launches Phase 3 Clinical Trial With Novel Alk Inhibitor In Non-Small Cell Lung Cancer Patients With Specific Gene Mutation

Helicos Announces First-Ever Direct Sequencing of Single Molecules of RNA

Life Technologies Initiates Suit Against Illumina Alleging Patent Infringement

PsoriasisDX and HairDX To Present “Pharmacogenomics In Dermatology And Cosmetics” During EADV Congress

BioPharm America™ 2009 in San Francisco Sets New Benchmark for Partnering Productivity in the US

RainDance Expands Sequence Enrichment Solution Capabilities with 20,000 Amplicon Library and Whole Genome Amplification Protocol

Perlegen Introduces BREVAGen™ Breast Cancer Risk Stratification Test

LifeSensors, Inc. Obtains Worldwide, Exclusive License to High Affinity “Ubiquitin Traps”

Merck and QIAGEN Collaborate to Accelerate Access to Cervical Cancer Vaccination and Screening in Developing Countries

Bio-Computing a Major Focus of 22nd Annual SC Conference

Genzyme Provides Update on Cerezyme and Fabrazyme Supply

Pluristem Therapeutics Doses First Patient in U.S. With Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease

Top 20 Pharma Firms to Hunt for Deals at BIO-Europe 2009

Genetic Hair Loss Test Now Introduced In Australia Through HairDX Distribution Agreement With Advanced Hair Studio

TRADE NEWS: Agilent Technologies Adds Human Exon Kit to Next-Generation-Sequencing Target Enrichment Portfolio

Curis to Present at Maxim Group Growth Conference 2009

Helicos Presents at Cold Spring Harbor Laboratories Personal Genomes and CHI Next Generation Sequencing Meetings

Mentor Capital, Inc. Completes 2nd Year Audit for OTCBB Move; Reporting $0.16 Per Share in Basic Earnings

BioForward Announces Winners of Biotechnology Vision Summit’s Emerging Company Showcase

Sloning Closes Growth Financing Round Led by LBBW Venture

NABsys Expands Leadership Team with Appointment of Stan Rose to Board of Directors

Dicerna Pharmaceuticals to Present at 2009 Biologics Drug Delivery & Beyond Conference

Biogen Idec Commences Tender Offer for Facet Biotech

PerkinElmer Launches Columbus™ 2.0 High Content Screening Platform for High-Volume Image Data Management and Analysis

Enzo Biochem and National Institutes of Health to Cooperate in Development of Enzo’s Novel Therapeutic Candidate for Treatment of Autoimmune Uveitis

Pacific Biosciences Expands Mission and Prepares for Commercialization

ZymoGenetics Appoints Dennis M. Miller, Ph.D., Senior Vice President, Research and Preclinical Development

From Ancient Bones to the Future of DNA Technologies: Forensic Experts Gather for Exclusive Symposium on Human Identity

Enzo Biochem’s Life Sciences Unit Introduces Novel System for Simultaneous Live-Cell Imaging of Nuclear Components

Navigenics Welcomes Michael Critelli to Board of Directors

Roche’s xCELLigence System and FuGENE® HD Transfection Reagent Minimize Cytotoxic Effects in the Detection of Bax-Induced Apoptosis

RainDance Technologies and CLC bio Collaborate to Develop Specialized Software Solutions for Targeted Resequencing

World-Class Scholars to Use Evolutionary Theory in Search for Solutions to High-Risk Adolescent Behavior

EBD Group and Defined Health Form an Alliance on Conference Content

Alnylam to Webcast Presentation at UBS Global Life Sciences Conference

Bioheart Inc. Announces Positive Results in the MARVEL Phase II/III Clinical Trial

Research and Markets: Principles of Genetics, Take Note!, 4th Edition

Enzo Biochem to Present at UBS Global Life Sciences Conference

PerkinElmer Purchases GE Healthcare’s Catalog Radiochemicals, SPA Reagents and Cytostar-T Plate Assets

Applied Biosystems Launches New Genomic Analysis Tools that Simplify Disease Research

Inovio Biomedical CEO to Present at MIT Technology Review Emerging Technology Conference

Fluidigm and Quimica Valaner Team Together in Mexican Distribution Deal

Breakthrough Genetic Test Helps Doctors Assess Risk Of Developing Psoriatic Arthritis (PsA)

Cipher Uses DSG’s EDC in Effort to Give Hope to Severe Acne Sufferers

7 Million Babies and Children and 6 Million Hispanics in the U.S. Have Acid Reflux

FDA and EMEA Grant Orphan Drug Designation for Antisense Pharma's Investigational Drug Trabedersen in Pancreatic Carcinoma

Osiris Therapeutics to Present at ThinkEquity and UBS Conferences

ACAM Partners with Jonathan Wright, MD and Daved Rosensweet, MD to Produce Comprehensive Hormone Seminar

Genzyme’s Alemtuzumab for Multiple Sclerosis Shows Durable Treatment Benefit in Review of Four-Year Phase 2 Trial Data

Data Supporting Unique Efficacy of TYSABRI Presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis

LabCorp is Scheduled to Present at the UBS 2009 Global Life Sciences Conference

BioMarker Strategies Raises $1.7 Million, Including Investment by Abell Foundation

New Ohio Bioscience Resource Directory Keeps Pace with Industry Sector’s Growth

American Diversified Holdings Corporation to Be Featured Presenter at the International Stem Cell Network's New York City Symposium

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Morgan Stanley Conference

NATURE REVIEWS DRUG DISCOVERY Publishes Epizyme-authored Paper on Protein Methyltransferases

Enzo Biochem to Present at Thomas Weisel Partners 2009 Healthcare Conference

Constellation Pharmaceuticals Appoints Renowned Cancer Biologist Edward E. Harlow, Jr., Ph.D. as Company’s CSO

Complete Genomics Demonstrates Its Technology’s Potential by Sequencing 14 Human Genomes for Customers

Inspire Wins North Carolina Health & Life Sciences Award for Cystic Fibrosis Development Program

Cytori Therapeutics Announces Fall U.S. Medical Conference Presentation Schedule; Interim RESTORE-2 Results to be Reported in December

Neuralstem Receives Notice of Patent Allowance